ClinicalTrials.govpublic full text
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
glioblastoma, vegf, 4-1bb, cd137, immunotherapy, targeted therapy, ctx-009, ctx-471, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853405
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.